Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
The field of apheresis consumables and equipment has experienced significant growth in recent years, driven by advancements in technology and increasing demand for blood component therapies. As healthcare needs evolve, the market is set to expand even further, supported by rising awareness and innovation. Let’s explore the current market size, key growth drivers, emerging trends, major players, and regional dynamics shaping this industry.
Market Size and Anticipated Growth Trajectory for Apheresis Consumables and Equipment
The apheresis consumables and equipment market has demonstrated rapid expansion, with revenue projected to rise from $3.76 billion in 2025 to $4.16 billion in 2026, representing a compound annual growth rate (CAGR) of 10.7%. This growth during the past period has been primarily driven by the limited automation in apheresis procedures, ongoing reliance on manual devices, heightened awareness around hematology and renal disease management, increased blood donation initiatives, and the use of traditional filtration and separation techniques.
Looking ahead, the market is forecasted to continue its upward trajectory by reaching $6.29 billion by 2030, with an expected CAGR of 10.9%. This surge reflects advancements in automated apheresis technologies, a growing demand for plasma-derived therapies, the broadening scope of stem cell collection procedures, stricter regulations on disposables and devices, and the integration of digital monitoring and IoT-enabled solutions. Key trends shaping the future market include a rising preference for automated devices, greater utilization of disposable kits and tubing sets, expansion of plasma and plateletpheresis procedures, adoption of cutting-edge centrifugation and membrane filtration technologies, and enhanced focus on patient safety alongside improved blood component quality.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2476&type=smp
Factors Contributing to Market Expansion: Blood Disorders as a Major Driver
Globally increasing cases of blood disorders have heightened the need for effective blood transfusion solutions, fueling demand for apheresis equipment. These devices play a critical role in treating diseases like sickle cell anemia, leukemia, and various forms of cancer that require regular blood transfusions. For instance, the Leukemia and Lymphoma Society forecasts that 60,300 new leukemia diagnoses will occur in the USA, with one blood cancer diagnosis happening every three minutes, each necessitating immediate transfusion. Similarly, the American Society of Hematology reports that approximately 100,000 Americans live with sickle cell anemia, with an additional 2 million carrying the trait, all requiring apheresis-based transfusion support. According to the International Agency for Research on Cancer (IARC), by 2040, 16.3 million new cancer cases worldwide are expected, with cancer treatments demanding at least eight units of blood per patient per procedure, further driving the need for blood component collection and transfusion. This high prevalence of blood disorders significantly boosts the demand for apheresis consumables and equipment.
The Impact of Chronic Diseases on Apheresis Consumables and Equipment Market Growth
The growing prevalence of chronic diseases is anticipated to be a pivotal factor sustaining the growth of the apheresis consumables and equipment market. Chronic conditions—long-lasting illnesses typically without complete cures—require ongoing management, often involving targeted removal or collection of specific blood components. These include autoimmune disorders, familial hypercholesterolemia, sickle cell disease, and stem cell harvesting procedures.
For example, according to data from the National Library of Medicine in 2023, nearly 36% of US adults aged 50 and above are expected to have at least one chronic condition by 2035, with this figure projected to increase to almost 48% by 2050. This expanding population with chronic health issues is directly contributing to rising demand in the apheresis consumables and equipment sector.
Apheresis Consumables And Equipment Market Geographic Landscape: Which Region Dominates Industry Growth?
Market Segmentation: Identifying Areas of Largest Growth Potential in the Apheresis Consumables and Equipment Industry
The apheresis consumables and equipment market is categorized as follows:
1) By Product Type: Disposables and Devices
2) By Technology: Centrifugation and Membrane Filtration
3) By Procedure: Photopheresis, Plasmapheresis, LDL Apheresis, Plateletpheresis, Leukapheresis, Erythrocytapheresis, and Other Procedures
4) By Application: Renal Disease, Neurology, Hematology, and Additional Applications
Within these broad categories, disposables include items such as apheresis kits, tubing sets, filters, collection bags, and anticoagulants. Devices comprise automated apheresis machines, manual apheresis devices, centrifuges, and plasmapheresis systems.
Emerging Trends and Innovations Driving Long-Term Market Demand
Leading companies in the apheresis consumables and equipment sector are introducing updated products to enhance versatility and patient care. A notable example is the launch of the Amicus Extracorporeal Photopheresis (ECP) single-needle option, which enables blood collection and return through a single venous access point during photopheresis procedures.
In April 2023, Germany-based healthcare firm Fresenius Kabi unveiled this single-needle enhancement for its Amicus ECP System, adding new software versions for the Amicus Separator and Phelix Photoactivation Device, along with disposable kits designed for single or double-needle access. This innovation is especially beneficial for patients with limited venous access and is primarily used for extracorporeal photopheresis treatment of cutaneous T-cell lymphoma (CTCL).
Key Players and Competitive Landscape in the Apheresis Consumables and Equipment Market
Several prominent companies dominate the market, including Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Kawasumi Laboratories Inc., Fresenius SE & Co. KGaA, Terumo BCT, Braun Melsungen AG, Therakos Inc., HemaCare Corporation, Cerus Corporation, Kaneka Corporation, Nikkiso Co., Medica SpA, Terumo Corporation, Macopharma, Grifols S.A., Baxter International Inc., Fenwal Inc., Miltenyi Biotec GmbH, Infomed SA, Lmb Technologie GmbH, Medivators Inc., Nigale Biomedical Inc., Aferetica S.r.l., Apheresis Care Group, Beijing Meso-Tech Co. Ltd., Biegler GmbH, Brightwake Ltd., Cytosorbents Corporation, DePuy Synthes Companies, Guangzhou Daji Medical Science and Technology Co. Ltd., and Haier Biomedical. These companies are continuously innovating and expanding their product offerings to meet growing global demand.
Regional Market Overview: North America Leading While Asia-Pacific Shows Rapid Growth
In 2025, North America held the largest share of the global apheresis consumables and equipment market, supported by advanced healthcare infrastructure and widespread adoption of innovative technologies. Western Europe followed as the second-largest regional market. The report also includes detailed coverage of other key regions such as Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East, and Africa, highlighting the global reach and diverse growth opportunities within this sector.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
